Johnson & Johnson (NYSE:JNJ)
| 154.36 Delayed Data As of May 26 |  -0.05 / -0.03%Today’s Change | 150.11 Today|||52-Week Range 183.35 | -12.62% Year-to-Date |
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 154.41 |
| Today’s open | 154.65 |
| Day’s range | 154.20 - 155.26 |
| Volume | 6,845,396 |
| Average volume (3 months) | 7,782,080 |
| Market cap | $401.1B |
Data as of 4:00pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -13.84% |
| Earnings growth (this year) | +4.92% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +1.34% |
| P/E ratio | 32.4 |
| Price/Sales | 4.95 |
| Price/Book | 5.25 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | -1.70 | -0.40% |
| MRKMerck | -1.25 | -1.11% |
| NVONovo Nordisk | +0.57 | +0.35% |
| ABBVAbbVie | -1.02 | -0.74% |
Data as of 4:00pm ET, 05/26/2023
Financials
| Next reporting date | July 20, 2023 |
| EPS forecast (this quarter) | $2.62 |
| Annual revenue (last year) | $95.0B |
| Annual profit (last year) | $17.9B |
| Net profit margin | 18.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
